BiotechTube
Home/SynaptixBio/Dan Williams
DW

Dan Williams

Executive (likely Founder/CEO)

SynaptixBio

Therapeutic Areas

Rare Neurological DiseasesLeukodystrophies

SynaptixBio Pipeline

DrugIndicationPhase
H-ABC ProgramHypomyelination with Atrophy of the Basal Ganglia and Cerebellum (TUBB4A-related)Pre-clinical
Isolated Hypomyelination ProgramIsolated Hypomyelination (TUBB4A-related)Pre-clinical

Leadership Team at SynaptixBio

DU
Dr. Uwe Meya
Chief Medical Officer
View full SynaptixBio profile